Project Grant R01AG092460
Award Date
5/15/25
Completion Date
2/28/30
Dollars Obligated
$785K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This $459,076 federal Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) will support research into the early transcriptional and pathological changes in vulnerable brain regions during the prodromal stage of Alzheimer's disease (AD). The project will leverage single-nucleus RNA sequencing and targeted mass spectrometry analysis of postmortem brain samples from individuals with early-stage AD pathology to profile gene expression changes and identify...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,257,275 to the University of Toledo Health Science Campus Division to conduct a comprehensive investigation into the protein kinase signaling networks associated with the progression of Alzheimer's disease (AD). The key deliverables include: Identification of protein kinase networks and nodes linked to AD progression through an unbiased protein kinase activity array approach, combined with...
This $717,709 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to Weill Medical College of Cornell University aims to discover Alzheimer's disease (AD)-relevant cellular mechanisms underlying the propagation of misfolded tau aggregates in human neurons. The research will utilize advanced proteomic techniques, including affinity purification mass spectrometry and transcriptomics, in combination with newly generated knockin human induced pluripotent stem cell...
The National Institute on Aging (NIA) awarded a $773,816 Project Grant (CFDA 93.866 - Aging Research) to the University of California, Irvine to conduct a comprehensive study on the molecular mechanisms underlying aberrant protein accumulation in Alzheimer's disease-related tauopathies. The project aims to generate cell-type-specific atlases of misprocessed RNAs and proteins in mouse models and human brain tissues to identify new pathways and protein interaction networks involved in...
This $328,000 federal Project Grant award is funded by the National Institute on Aging under the Aging Research program (CFDA 93.866). The grant supports the Alzheimer's Disease Organelle Proteome Task (ADOPT) pilot phase, which aims to quantitatively measure the organelle proteome to provide in-depth knowledge of organelle homeostasis and function in brain tissues during Alzheimer's disease progression. The interdisciplinary research team will utilize a genetic organelle tagging approach to...
This federal Project Grant award under the National Institute on Aging's Aging Research program (CFDA 93.866) provides $913,225 to St. Jude Children's Research Hospital Inc. to conduct a comprehensive research project on Alzheimer's disease (AD) and related dementias (ADRD). The project aims to systematically characterize the role of U1 small nuclear ribonucleoprotein (U1 SNRNP) proteinopathy and its impact on RNA splicing dysfunction in the pathogenesis of AD/ADRD. The research will leverage...
This federal Project Grant award of $816,661 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a research initiative by the Regents of the University of California, San Francisco (UCSF) to comprehensively map the impact of tau pathology on the proteome, which is expected to be mediated in part through disruptions in mRNA splicing. The research leverages AD mouse models and human iPSC tauopathy models to discover protein drivers of tauopathy and validate such drivers in...
This federal Project Grant award, funded by the National Institute on Aging (CFDA 93.866 - Aging Research), provides $6,226,692 to The Trustees of Columbia University in the City of New York to conduct research on the role of neuronal hyperexcitability and proteostasis (protein homeostasis) in the progression of Alzheimer's disease. The research aims to identify key early events in Alzheimer's disease pathology, particularly in the locus coeruleus and hippocampus regions of the brain, and...
This federal Project Grant award of $1,118,700.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) to New York University School of Medicine will support research to elucidate the role of pathological tau protein in disrupting endosomal microautophagy (EMI), a critical protein degradation pathway affected in Alzheimer's disease. The research aims to determine which components of the EMI pathway are most vulnerable to tau pathology and whether restoring EMI function can...
This Project Grant award, with the federal grant ID R01AG091534, was provided by the National Institute on Aging under the Aging Research Federal Grant Program (CFDA 93.866). The $795,436 award, with a performance period from April 1, 2025 to February 28, 2030, will fund a research study by Rutgers, The State University of New Jersey to elucidate the role of the glycoproteome in Alzheimer's disease and related dementias (AD/ADRD). The study aims to identify glycopeptiforms related to AD/ADRD...